If α-synuclein seeds are taken up at presynaptic regions, as we have shown here, and seed-dependent aggregation occurs at these regions soon afterwards, these steps could be good targets for treatment or prevention for neurodegenerative diseases. This evidence concerns the gene SNCA and neurodegenerative disease.